These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 10612270)

  • 1. A comparative assessment of the risks and benefits of zopiclone: a review of 15 years' clinical experience.
    Hajak G
    Drug Saf; 1999 Dec; 21(6):457-69. PubMed ID: 10612270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zopiclone. A review of its pharmacological properties and therapeutic efficacy as an hypnotic.
    Wadworth AN; McTavish D
    Drugs Aging; 1993; 3(5):441-59. PubMed ID: 8241608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zopiclone. An update of its pharmacology, clinical efficacy and tolerability in the treatment of insomnia.
    Noble S; Langtry HD; Lamb HM
    Drugs; 1998 Feb; 55(2):277-302. PubMed ID: 9506247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia.
    Holm KJ; Goa KL
    Drugs; 2000 Apr; 59(4):865-89. PubMed ID: 10804040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zopiclone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic.
    Goa KL; Heel RC
    Drugs; 1986 Jul; 32(1):48-65. PubMed ID: 2874974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zopiclone: is it a pharmacologic agent for abuse?
    Cimolai N
    Can Fam Physician; 2007 Dec; 53(12):2124-9. PubMed ID: 18077750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative clinical profiles of triazolam versus other shorter-acting hypnotics.
    Jonas JM; Coleman BS; Sheridan AQ; Kalinske RW
    J Clin Psychiatry; 1992 Dec; 53 Suppl():19-31; discussion 32-3. PubMed ID: 1336776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescribing short-acting hypnosedatives. Current recommendations from a safety perspective.
    Wheatley D
    Drug Saf; 1992; 7(2):106-15. PubMed ID: 1605897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically important drug interactions with zopiclone, zolpidem and zaleplon.
    Hesse LM; von Moltke LL; Greenblatt DJ
    CNS Drugs; 2003; 17(7):513-32. PubMed ID: 12751920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adverse effects of zopiclone].
    Bramness JG; Olsen H
    Tidsskr Nor Laegeforen; 1998 May; 118(13):2029-32. PubMed ID: 9656789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects.
    Voderholzer U; Riemann D; Hornyak M; Backhaus J; Feige B; Berger M; Hohagen F
    Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):117-23. PubMed ID: 11697572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerance of zopiclone in insomniac geriatric patients.
    Elie R; Deschenes JP
    Pharmacology; 1983; 27 Suppl 2():179-87. PubMed ID: 6366822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zopiclone and nitrazepam: a multicenter placebo controlled comparative study of efficacy and tolerance in insomniac patients in general practice.
    Anderson AA
    Sleep; 1987; 10 Suppl 1():54-62. PubMed ID: 3326116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dependency of non-benzodiazepine hypnotics. Two case reports].
    Ströhle A; Antonijevic IA; Steiger A; Sonntag A
    Nervenarzt; 1999 Jan; 70(1):72-5. PubMed ID: 10087521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zopiclone and triazolam in insomnia associated with generalized anxiety disorder: a placebo-controlled evaluation of efficacy and daytime anxiety.
    Fontaine R; Beaudry P; Le Morvan P; Beauclair L; Chouinard G
    Int Clin Psychopharmacol; 1990 Jul; 5(3):173-83. PubMed ID: 2230061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zopiclone versus flurazepam in insomnia: prolonged administration and withdrawal.
    Elie R; Lavoie G; Bourgouin J; Le Morvan P
    Int Clin Psychopharmacol; 1990 Oct; 5(4):279-86. PubMed ID: 2081899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind placebo-controlled trial of zopiclone 7.5 mg and temazepam 20 mg in insomnia.
    Ngen CC; Hassan R
    Int Clin Psychopharmacol; 1990 Jul; 5(3):165-71. PubMed ID: 2230060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon.
    Terzano MG; Rossi M; Palomba V; Smerieri A; Parrino L
    Drug Saf; 2003; 26(4):261-82. PubMed ID: 12608888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis.
    Dündar Y; Dodd S; Strobl J; Boland A; Dickson R; Walley T
    Hum Psychopharmacol; 2004 Jul; 19(5):305-22. PubMed ID: 15252823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypnotic dependence: zolpidem and zopiclone too.
    Prescrire Int; 2001 Feb; 10(51):15. PubMed ID: 11503851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.